amotosalen
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started May 31, 2020 (NCT04372979)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Loading structure…
SMILES
Cc1oc2c(C)c3oc(=O)cc(C)c3cc2c1COCCN- Mol. weight
- 301.34 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2110621 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04372979 | Phase 3 | May 31, 2020 | Direction Centrale du Service de Santé des Armées, University of Grenoble |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Direction Centrale du Service de Santé des Armées | Government | 1 | 1 | 1 | 2020 |
| University of Grenoble | Academic/Hospital | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1